Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Are The Current (2025) And Forecast (2029) Sizes Of The Irritable Bowel Syndrome (IBS) Treatment Market?
The irritable bowel syndrome (ibs) treatment market size has experienced significant growth in recent years. It is projected to increase from $2.79 billion in 2024 to $3.06 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.8%. This historical expansion can be primarily ascribed to factors like the rising prevalence of ibs, enhanced patient awareness, stress and lifestyle influences, the existence of patient advocacy and support groups, and healthcare reimbursement policies.
The irritable bowel syndrome (IBS) treatment market is poised for significant expansion over the next few years. It is projected to reach $4.9 billion by 2029, achieving a compound annual growth rate (CAGR) of 12.5%. This growth throughout the forecast period is fueled by factors such as patient-centric healthcare models, the development of microbial therapies, the integration of blockchain in healthcare, a focus on patient-reported outcomes (PROs), efficient regulatory fast-track programs, and advancements in health data interoperability. Prominent trends expected during this period include the wider adoption of digital health solutions, continuous progress in diagnostic technologies, a surge in research and development investments, strategic collaborations and partnerships, and the increasing availability of non-pharmacological therapies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11978&type=smp
What Are The Drivers Pushing New Developments In The Irritable Bowel Syndrome (IBS) Treatment Market?
The increasing occurrence of irritable bowel syndrome (IBS) is anticipated to fuel the expansion of the irritable bowel syndrome treatment market in the future. IBS itself is a chronic gastrointestinal disorder primarily impacting the large intestine (colon). This rise in IBS prevalence stems from factors such as unhealthy lifestyles, poor dietary choices, environmental pollution exposure, and elevated stress levels. Treatments for IBS aim to lessen the intensity and regularity of its symptoms, thereby enhancing patients’ quality of life and empowering them to manage their condition more effectively. For example, data from the International Foundation for Gastrointestinal Disorders (IFFGD), a US-based non-profit education and research organization, indicates that approximately 5–10% of the worldwide population had IBS in 2023, with between 25 and 45 million individuals affected in the United States. Consequently, the expanding prevalence of irritable bowel syndrome (IBS) is a key driver for the growth of the IBS treatment market.
How Is The Irritable Bowel Syndrome (IBS) Treatment Market Classified Into Different Segments?
The irritable bowel syndrome (ibs) treatmentmarket covered in this report is segmented –
1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs
2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Users: Hospitals, Clinics, Homecare Settings
Subsegments:
1) By Lubiprostone: Chronic Idiopathic Constipation Treatment; Irritable Bowel Syndrome with Constipation (IBS-C) Treatment
2) By Linaclotide: IBS-C Treatment; Chronic Idiopathic Constipation Treatment
3) By Eluxadoline: IBS with Diarrhea (IBS-D) Treatment
4) By Rifaximin: IBS-D Treatment; Small Intestinal Bacterial Overgrowth (SIBO) Treatment
5) By Alosetron: Severe IBS-D Treatment for Women
6) By Other Drugs: Prucalopride; Tenapanor; Plecanatide
How Are Trends Influencing The Irritable Bowel Syndrome (IBS) Treatment Market?
Product innovations have emerged as a significant and popular trend in the irritable bowel syndrome (IBS) market. Key players in the irritable bowel syndrome (IBS) market are concentrating their efforts on developing new, innovative, and advanced products to strengthen their market position. For instance, in April 2022, Ardelyx, a US-based biotechnology company, launched IBSRELA, a first-in-class treatment for IBS-C in adults. It stands as the first and only NHE3 inhibitor available for treating adult irritable bowel syndrome with constipation (IBS-C). IBSRELA, the first Ardelyx medicine to receive FDA approval, represents the first novel mechanism therapy for IBS-C (irritable bowel syndrome-constipation) developed in almost ten years, providing a vital new treatment option for the constipation, bloating, and stomach pain symptoms of this debilitating disorder.
Who Are The Major Companies Operating In The Irritable Bowel Syndrome (IBS) Treatment Market?
Major companies operating in the irritable bowel syndrome (IBS) treatment market include Pfizer Inc., Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bausch Health Companies Inc., Ironwood Pharmaceuticals Inc., Sebela Pharmaceuticals Inc., Prometheus Laboratories Inc., RedHill Biopharma Ltd., Ardelyx Inc., Cosmo Technologies Ltd., Renexxion Ireland Ltd., 4D Pharma plc, Biora Therapeutics Inc.
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Irritable Bowel Syndrome (IBS) Treatment Industry?
North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the irritable bowel syndrome (IBS) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Irritable Bowel Syndrome (IBS) Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=11978&type=smp
Browse Through More Reports Similar to the Global Irritable Bowel Syndrome (IBS) Treatment Market 2025, By The Business Research Company
Aerospace Composites Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aerospace-composites-global-market-report
Aerospace Fasteners Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aerospace-fasteners-global-market-report
Aerospace Foams Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/aerospace-foams-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model